Method for down-regulation of vegf

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070184023A1
SERIAL NO

10577489

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides for novel immunogenic variants of VEGF (vascular endothelial growth factor) which are useful in active specific immunotherapy against diseases that are characterized by overexpression of VEGF. The invention also relates to methods of treating such diseases (for instance cancer) as well as to various tools in molecular biology that assist in the provision of the immunogenic variants.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHARMEXA A/SDANE HESS HOLM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dal, Degan Florence Horsholm, DK 2 15
Klysner, Steen Horsholm, DK 11 72
Rasmussen, Peter Birk Horsholm, DK 27 395
Renard, Valery Horsholm, DK 2 15
Volck, Birgitte Horsholm, DK 1 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation